Cargando…
The role of PI3-K/Akt signal pathway in the antagonist effect of CEPO on CHF rats
The possible role of phosphoinositide 3-kinase (PI3-K)/protein kinase B (Akt) signal pathway in the antagonist effect of carbamylated erythropoietin (CEPO) on chronic heart failure (CHF) in rats was investigated. Twenty of 120 rats were randomly selected as the control group, and the remaining rats...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257438/ https://www.ncbi.nlm.nih.gov/pubmed/30542471 http://dx.doi.org/10.3892/etm.2018.6822 |
_version_ | 1783374321991811072 |
---|---|
author | Huang, Zhaoqi Xu, Wei Wu, Jinlei Chen, Shengqiang Chen, Ximing |
author_facet | Huang, Zhaoqi Xu, Wei Wu, Jinlei Chen, Shengqiang Chen, Ximing |
author_sort | Huang, Zhaoqi |
collection | PubMed |
description | The possible role of phosphoinositide 3-kinase (PI3-K)/protein kinase B (Akt) signal pathway in the antagonist effect of carbamylated erythropoietin (CEPO) on chronic heart failure (CHF) in rats was investigated. Twenty of 120 rats were randomly selected as the control group, and the remaining rats as the model group. Rats in the model group received intraperitoneal injection of isoproterenol, those in the control group underwent intraperitoneal injection of equivalent normal saline. Rats with successful model establishment were divided into 4 groups, i.e. CHF group, CEPO group, LY294002 (LY) group and CEPO + LY group. Rats in the CEPO group underwent intraperitoneal injection of CEPO, while those in the CHF group received intraperitoneal injection of equivalent normal saline at the same time, those in the LY group received intraperitoneal injection of LY after model establishment, and those in the CEPO + LY group received the combined intraperitoneal injection of CEPO and LY simultaneously. Indicators for hemodynamics were determined using BL-410S bio-functional experiment system, including heart rate (HR), left ventricular end-diastolic pressure (LVEDP), left ventricular systolic pressure (LVSP) and maximal increased rate of left ventricular pressure (LVP)/maximal reduced rate of LVP (±dp/dt(max)). Western blotting assay was utilized to determine the changes in activity of PI3-K/Akt signal pathway. LVSP and ±dp/dt(max) in the CHF, the CEPO, the CEPO + LY and the LY groups were significantly lower than those in the control group (P<0.05); LVSP and ±dp/dt(max) in the CEPO group were also elevated significantly compared with CHF, LY and CEPO + LY groups (P<0.05) with significant decreases in LVEDP and HR (P<0.05); compared with the CHF group, LVSP and ±dp/dt(max) in the LY group were each significantly decreased (P<0.05), in the LY group, pAkt level was significantly lower than that in the CHF group (P<0.05). In conclusion, CEPO can generate the antagonist effect on CHF in rats through activation of PI3-K/Akt signal pathway. |
format | Online Article Text |
id | pubmed-6257438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-62574382018-12-12 The role of PI3-K/Akt signal pathway in the antagonist effect of CEPO on CHF rats Huang, Zhaoqi Xu, Wei Wu, Jinlei Chen, Shengqiang Chen, Ximing Exp Ther Med Articles The possible role of phosphoinositide 3-kinase (PI3-K)/protein kinase B (Akt) signal pathway in the antagonist effect of carbamylated erythropoietin (CEPO) on chronic heart failure (CHF) in rats was investigated. Twenty of 120 rats were randomly selected as the control group, and the remaining rats as the model group. Rats in the model group received intraperitoneal injection of isoproterenol, those in the control group underwent intraperitoneal injection of equivalent normal saline. Rats with successful model establishment were divided into 4 groups, i.e. CHF group, CEPO group, LY294002 (LY) group and CEPO + LY group. Rats in the CEPO group underwent intraperitoneal injection of CEPO, while those in the CHF group received intraperitoneal injection of equivalent normal saline at the same time, those in the LY group received intraperitoneal injection of LY after model establishment, and those in the CEPO + LY group received the combined intraperitoneal injection of CEPO and LY simultaneously. Indicators for hemodynamics were determined using BL-410S bio-functional experiment system, including heart rate (HR), left ventricular end-diastolic pressure (LVEDP), left ventricular systolic pressure (LVSP) and maximal increased rate of left ventricular pressure (LVP)/maximal reduced rate of LVP (±dp/dt(max)). Western blotting assay was utilized to determine the changes in activity of PI3-K/Akt signal pathway. LVSP and ±dp/dt(max) in the CHF, the CEPO, the CEPO + LY and the LY groups were significantly lower than those in the control group (P<0.05); LVSP and ±dp/dt(max) in the CEPO group were also elevated significantly compared with CHF, LY and CEPO + LY groups (P<0.05) with significant decreases in LVEDP and HR (P<0.05); compared with the CHF group, LVSP and ±dp/dt(max) in the LY group were each significantly decreased (P<0.05), in the LY group, pAkt level was significantly lower than that in the CHF group (P<0.05). In conclusion, CEPO can generate the antagonist effect on CHF in rats through activation of PI3-K/Akt signal pathway. D.A. Spandidos 2018-12 2018-10-02 /pmc/articles/PMC6257438/ /pubmed/30542471 http://dx.doi.org/10.3892/etm.2018.6822 Text en Copyright: © Huang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Huang, Zhaoqi Xu, Wei Wu, Jinlei Chen, Shengqiang Chen, Ximing The role of PI3-K/Akt signal pathway in the antagonist effect of CEPO on CHF rats |
title | The role of PI3-K/Akt signal pathway in the antagonist effect of CEPO on CHF rats |
title_full | The role of PI3-K/Akt signal pathway in the antagonist effect of CEPO on CHF rats |
title_fullStr | The role of PI3-K/Akt signal pathway in the antagonist effect of CEPO on CHF rats |
title_full_unstemmed | The role of PI3-K/Akt signal pathway in the antagonist effect of CEPO on CHF rats |
title_short | The role of PI3-K/Akt signal pathway in the antagonist effect of CEPO on CHF rats |
title_sort | role of pi3-k/akt signal pathway in the antagonist effect of cepo on chf rats |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257438/ https://www.ncbi.nlm.nih.gov/pubmed/30542471 http://dx.doi.org/10.3892/etm.2018.6822 |
work_keys_str_mv | AT huangzhaoqi theroleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats AT xuwei theroleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats AT wujinlei theroleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats AT chenshengqiang theroleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats AT chenximing theroleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats AT huangzhaoqi roleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats AT xuwei roleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats AT wujinlei roleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats AT chenshengqiang roleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats AT chenximing roleofpi3kaktsignalpathwayintheantagonisteffectofcepoonchfrats |